跳至主要内容
临床试验/NCT04544085
NCT04544085Unknown不适用

A Study on Noise Exposure Status and the Effect of Noise Management in Pediatric Intensive Care Unit

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2020年7月16日最近更新:
适应症

试验速览

阶段
不适用
入组人数
204
试验地点
1
主要终点
Delirium incidence

研究概览

简要总结

This study has two stages. At the first stage,the investigators will try to use noise detectors to investigate the status of noise exposure in the pediatric intensive care unit(PICU) and to analyze the main noise sources in it. At the second stage,the investigators will try to evaluate the effect of noise management on noise exposure and health outcomes of the pediatric patients in PICU.The investigators hypothesize that noise exposure in PICU is higher than the standard.The investigators also hypothesize that the implementation of the noise management will improve the noise exposure and health outcomes of the pediatric patients in PICU.

详细描述

This study has two stages. At the first stage,the investigators will try to use noise detectors to investigate the status of noise exposure in the pediatric intensive care unit(PICU) and to analyze the main noise sources in it. At the second stage,the investigators will try to evaluate the effect of noise management on noise exposure and health outcomes of the pediatric patients in PICU.The investigators hypothesize that noise exposure in PICU is higher than the standard.The investigators also hypothesize that the implementation of the noise management will improve the noise exposure and health outcomes of the pediatric patients in PICU.

1.For the investigation of the status of noise exposure:

(1) Preparation of noise monitor equipment: select noise detectors conforming to the national standard. All noise detectors used in the study are of the same brand; (2) Use of noise monitor: set the mode of noise monitor according to the national standard: place the monitor in accordance with the requirements;(3) All the data of noise exposure will be collected and sorted out by the investigator. (4) Spss20.0 software is used for descriptive analysis and statistical inference. Mean ± standard deviation, median and quartile are used to describe measurement data, while frequency and percentage are used to describe counting data. Comparison between groups: when the measurement data obey normal distribution and the variance is homogeneous, two independent sample t-test are used to compare whether there is statistical difference between the two groups of indicators or index difference (measured value baseline value); if it does not obey normal distribution or the variance is uneven, non parametric statistical method is used; counting data: Chi square test is used to compare whether there is statistical difference between the two groups of index values, test level: α = 0.05 2.For the evaluation of the effect of noise management on noise exposure and health outcomes of the pediatric patients in PICU:

(1)General information and clinical data of patients will be collected through hospital electronic information system, ICU nursing records, cases, doctor's advice and consultation. The investigator will evaluate and record the delirium score of ICU children who met the inclusion criteria each shift . At the time of discharge, PICU duration, hospital stay, MV duration and in-hospital mortality were inquired by EMR. (2) Quality control of intervention implementation are as follows:① According to the research results of early promotion strategy, relevant training materials were made to carry out training and education for PICU medical staff;② During the implementation of the intervention, irregular sampling of medical staff was conducted to evaluate the implementation of the intervention and give timely feedback.(3) Collection of information:① The data of patients will be collected by the investigator;② Pediatric delirium score: in order to ensure the quality of the study, the investigator will conduct random sampling and assess the delirium of children in the same patient with the nurses from time to time to investigate the evaluation quality;③ Input the data into EpiData, set reasonable numerical boundary value and logical check items. If there is logical error, check the original data for correction, and import the data into spss20.0 for statistical analysis.

(4) Sample size assessment: the assessment of sample size in experimental research can also be divided into measurement data and counting data. The main outcome measures are delirium rate and noise exposure. Therefore, the incidence of delirium will be used as the rate to calculate the sample size.According to the calculation formula of the rate: n = (U α + U β) 22P (1-p) / (P1-P2) 2, the sample size of the control group and the intervention group are calculated. Uα=1.64,Uβ=0.84。P1 and P2 are the estimated values of delirium incidence before and after the intervention, and P is the total rate. The references showed that P1 = 33%, P2 = 14%.The sample size calculated by the formula is: (1.64 + 0.84) 2 * 2 * 0.47 * 0.53 / 0.192 = 85 cases, plus 20% of the sample loss, that is, 102 cases in the control group and 102 cases in the intervention group (5)Statistical Analysis:①Data set: use EpiData 3.1 software to establish the data set, and clean up and check the data;② The data will be imported into spss20.0 for statistical analysis. Descriptive analysis and statistical inference will be carried out. Mean ± standard deviation, median and quartile are used to describe measurement data, while frequency and percentage are used to describe counting data. Comparison between groups: when the measurement data obeys normal distribution and the variance is homogeneous, two independent sample t-test is used to compare whether there is statistical difference in the indicators or index difference (measured value baseline value) between the two groups; if the measurement data does not obey the normal distribution or the variance is uneven, non parametric statistical method is used; counting data: Chi square test is used to compare whether there is statistical difference between the two groups of patients Level: α = 0.05.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged ≤ 18 years
  • The predicted PICU LOS ≥12 hours
  • The informed consent of the child's guardian was obtained

排除标准

  • Patients with delirium on admission
  • Patients in a coma (Richmond Agitation Sedation Scale[RASS]-4 or -5) all through their stay in PICU
  • Patients with mental disorders or mental retardation, who continue to use antipsychotic drugs
  • Patients undergoing neurosurgery and neurology surgery
  • Hearing or visual impairment
  • Non Chinese or English language users
  • Missed or incomplete delirium score

结局指标

主要结局

Delirium incidence

时间窗: Up to 1 month

Delirium screening is performed using the Cornell assessment of pediatric delirium(CAPD).Delirium will be screened every 12 hours(at 8:00a.m.\&20:00p.m.) until the patient is transferred out of PICU or drops out

Noise exposure

时间窗: Average of 1 weak

Noise is measured in decibels.The noise exposure in PICU will be described in Leq,Lmax,Lmin

次要结局

  • Duration of mechanical ventilation(MV)(60 days after the enrollment)
  • Medical staff's knowledge of noise management(1 hour within the end of the lecture on noise management for medical staff)
  • PICU length of stay(LOS)(60 days after the enrollment)
  • Hospital length of stay(LOS)(60 days after the enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

招募中
1 期
A Study of Tetrathiomolybdate (TM) Plus CapecitabineTriple Negative Breast CancerResidual Disease
NCT06134375Dartmouth-Hitchcock Medical Center204
进行中(未招募)
1 期
Clinical study to investigate the activity and safety of anti-PD-L1 antibody (Durvalumab) in patients with advanced malignant pleural mesothelioma after a previous therapy
EUCTR2016-000617-67-ITIRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI57
进行中(未招募)
不适用
Phase II trial assessing the impact on instrumental and daily living autonomy of a chemotherapy regimen with bi-weekly docetaxel in the treatment of metastatic breast cancer in patients over the age of 70 - Bi-weekly docetaxelHR+ or HR- metastatic adenocarcinoma of the breast with a measurable target (RECIST criteria) in patients aged 70 or overMedDRA version: V5Level: LLTClassification code 10027475
EUCTR2004-002839-10-GBFédération Nationale des Centres de Lutte Contre le Cancer58
进行中(未招募)
不适用
Phase II trial assessing the impact on instrumental and daily living autonomy of chemotherapy with bi-weekly docetaxel in the treatment of metastatic or locally advanced non-small cell lung cancer in patients over the age of 70. - bi-weekly docetaxel-NSCLCElderly patients form an increasing proportion of the lung cancer population. The median age of patients with a bronchial cancer is 68 years old (Gridelli et al., 1997). In a more recent study, Ng et al. (2004) showed that 46% of patients are over the age of 70 when the NSCLC is diagnosed. Around 37% of patients aged over 70 are not treated, in contrast with younger patients.MedDRA version: V5Level: LLTClassification code 10029514
EUCTR2005-000068-23-GBFédération Nationale des Centres de Lutte Contre le Cancer60
已完成
1 期
A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or ObesityOverweightObesity
NCT06478563Novo Nordisk A/S133